McKesson Corporation (MCK): Price and Financial Metrics
McKesson Corporation (MCK)
Today's Latest Price: $152.00 USD
Updated Aug 7 12:00am
Add MCK to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 68 in Medical - Services
See all "A" rated Strong Buy stocks
MCK Stock Summary
- Mckesson Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.23% of US listed stocks.
- With a price/sales ratio of 0.11, Mckesson Corp has a higher such ratio than only 3.73% of stocks in our set.
- In terms of volatility of its share price, MCK is more volatile than just 2.91% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Mckesson Corp, a group of peers worth examining would be LOW, SUMR, AFH, RAD, and JWN.
- MCK's SEC filings can be seen here. And to visit Mckesson Corp's official web site, go to www.mckesson.com.
MCK Stock Price Chart Technical Analysis Charts
MCK Price/Volume Stats
| Current price | $152.00 | 52-week high | $172.18 |
| Prev. close | $151.75 | 52-week low | $112.60 |
| Day low | $150.73 | Volume | 569,000 |
| Day high | $152.11 | Avg. volume | 2,971,790 |
| 50-day MA | $153.63 | Dividend yield | 1.08% |
| 200-day MA | $145.65 | Market Cap | 24.65B |
McKesson Corporation (MCK) Company Bio
Mckesson Corporation partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. The company was founded in 1833 and is based in San Francisco, California.
MCK Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $152.00 | $242.93 | 58% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Mckesson Corp. To summarize, we found that Mckesson Corp ranked in the 58th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 59%. The most interesting components of our discounted cash flow analysis for Mckesson Corp ended up being:
- Mckesson Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than only 14.53% of tickers in our DCF set.
- Relative to other stocks in its sector (Healthcare), Mckesson Corp has a reliance on debt greater than 67.6% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 55% |
| 1% | 57% |
| 2% | 58% |
| 3% | 60% |
| 4% | 61% |
| 5% | 63% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MCK, try RSCF, QDEL, UHS, PBH, and UNH.
Loading social stream, please wait...